Ag Biotechnology

MMJ Group Holdings Ltd (ASX:MMJ) Investment Portfolio Report

🕔6/14/2019 8:35:47 AM

MMJ Group Holdings Limited (ASX:MMJ) (OTCMKTS:MMJJF) provides the MMJ Investment Portfolio Report as at 31 May 2019. This report includes details of MMJ's net tangible asset per share as at 31 May 2019 pursuant to Listing Rule 4.12 as a listed investment company.

Read Full Article

THC Global Group Limited (ASX:THC) Granted Cannabis Manufacture Licence

🕔6/13/2019 9:10:20 AM

THC Global Group Limited (ASX:THC) (OTCMKTS:HDRPF) is pleased to advise that THC Global, through its wholly owned subsidiary Canndeo Limited, has been granted a Manufacture Licence for the production of extracts and tinctures of cannabis and cannabis resin from the Australian Office of Drug Control.

Read Full Article

MMJ Group Holdings Ltd (ASX:MMJ) Capital Management and Embark Ventures Appointment

🕔6/7/2019 8:50:27 AM

MMJ Group Holdings Limited (ASX:MMJ) (FRA:2P9) (OTCMKTS:MMJJF) is pleased to announce an on-market buy-back of up to 10m MMJ ordinary shares over the next 12 months ('buy-back') as part of its active approach to capital management.

Read Full Article

THC Global Group Limited (ASX:THC) Chairman's Address

🕔5/28/2019 10:36:57 AM

THC Global Group Limited (ASX:THC) (OTCMKTS:HDRPF) provides a copy of the address to be presented by the Chairman of THC Global, Mr Steven Xu at the 2019 Annual General Meeting to be held today.

Read Full Article

MMJ Group Holdings Ltd (ASX:MMJ) To Present at Investor Conference

🕔5/21/2019 8:22:27 AM

MMJ Group Holdings Limited (ASX:MMJ) (OTCMKTS:MMJJF) announced that its Chief Financial Officer, Jim Hallam, will attend and present in front of 200 investors at the forthcoming Finance News Network Investor Conference in Sydney on Tuesday, 21 May 2019 between 12:30pm and 2.30pm.

Read Full Article

VIDEO: Ellis Martin Report: Matinas BioPharma (NYSE:MTNB) Announces a Research Collaboration with ViiV Healthcare to Evaluate Formulation of Antiviral Drug Candidates

🕔5/20/2019 10:32:01 AM

In this segment of The Ellis Martin Report, Ellis speaks with Jerome Jabbour, the CEO of Matinas Biopharma (NYSE:MTNB). The company announced a research collaboration with ViiV Healthcare to evaluate formulation of antiviral drug candidates. Additionally, Mr. Jabbour will address Matinas' First Quarter 2019 Financial Results with an outlook toward the next 12 months.

Read Full Article

MMJ Group Holdings Ltd (ASX:MMJ) Investment in Volero Brands Inc

🕔5/16/2019 12:09:29 PM

MMJ Group Holdings Limited (ASX:MMJ) (OTCMKTS:MMJJF) has invested CAD2.5m for a 7.3% shareholding in privately-held Volero Brands Inc., a private company based in Canada which owns and manufactures the Flyte brand of vape pens and cartridges, as part of their CAD5m seed funding round.

Read Full Article